Saved in:
Bibliographic Details
Main Authors: González, Camila, Fuchs, Moritz, Santos, Daniel Pinto dos, Matthies, Philipp, Trenz, Manuel, Grüning, Maximilian, Chaudhari, Akshay, Larson, David B., Othman, Ahmed, Kim, Moon, Nensa, Felix, Mukhopadhyay, Anirban
Format: Preprint
Published: 2024
Subjects:
Online Access:https://arxiv.org/abs/2412.20498
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1866913672365867008
author González, Camila
Fuchs, Moritz
Santos, Daniel Pinto dos
Matthies, Philipp
Trenz, Manuel
Grüning, Maximilian
Chaudhari, Akshay
Larson, David B.
Othman, Ahmed
Kim, Moon
Nensa, Felix
Mukhopadhyay, Anirban
author_facet González, Camila
Fuchs, Moritz
Santos, Daniel Pinto dos
Matthies, Philipp
Trenz, Manuel
Grüning, Maximilian
Chaudhari, Akshay
Larson, David B.
Othman, Ahmed
Kim, Moon
Nensa, Felix
Mukhopadhyay, Anirban
contents Over time, the distribution of medical image data drifts due to factors such as shifts in patient demographics, acquisition devices, and disease manifestations. While human radiologists can adjust their expertise to accommodate such variations, deep learning models cannot. In fact, such models are highly susceptible to even slight variations in image characteristics. Consequently, manufacturers must conduct regular updates to ensure that they remain safe and effective. Performing such updates in the United States and European Union required, until recently, obtaining re-approval. Given the time and financial burdens associated with these processes, updates were infrequent, and obsolete systems remained in operation for too long. During 2024, several regulatory developments promised to streamline the safe rollout of model updates: The European Artificial Intelligence Act came into effect last August, and the Food and Drug Administration (FDA) issued final marketing submission recommendations for a Predetermined Change Control Plan (PCCP) in December. We provide an overview of these developments and outline the key building blocks necessary for successfully deploying dynamic systems. At the heart of these regulations - and as prerequisites for manufacturers to conduct model updates without re-approval - are clear descriptions of data collection and re-training processes, coupled with robust real-world quality monitoring mechanisms.
format Preprint
id arxiv_https___arxiv_org_abs_2412_20498
institution arXiv
publishDate 2024
record_format arxiv
spellingShingle Regulating radiology AI medical devices that evolve in their lifecycle
González, Camila
Fuchs, Moritz
Santos, Daniel Pinto dos
Matthies, Philipp
Trenz, Manuel
Grüning, Maximilian
Chaudhari, Akshay
Larson, David B.
Othman, Ahmed
Kim, Moon
Nensa, Felix
Mukhopadhyay, Anirban
Computers and Society
Over time, the distribution of medical image data drifts due to factors such as shifts in patient demographics, acquisition devices, and disease manifestations. While human radiologists can adjust their expertise to accommodate such variations, deep learning models cannot. In fact, such models are highly susceptible to even slight variations in image characteristics. Consequently, manufacturers must conduct regular updates to ensure that they remain safe and effective. Performing such updates in the United States and European Union required, until recently, obtaining re-approval. Given the time and financial burdens associated with these processes, updates were infrequent, and obsolete systems remained in operation for too long. During 2024, several regulatory developments promised to streamline the safe rollout of model updates: The European Artificial Intelligence Act came into effect last August, and the Food and Drug Administration (FDA) issued final marketing submission recommendations for a Predetermined Change Control Plan (PCCP) in December. We provide an overview of these developments and outline the key building blocks necessary for successfully deploying dynamic systems. At the heart of these regulations - and as prerequisites for manufacturers to conduct model updates without re-approval - are clear descriptions of data collection and re-training processes, coupled with robust real-world quality monitoring mechanisms.
title Regulating radiology AI medical devices that evolve in their lifecycle
topic Computers and Society
url https://arxiv.org/abs/2412.20498